James S. Kaufman

10.1k total citations · 3 hit papers
114 papers, 6.2k citations indexed

About

James S. Kaufman is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Emergency Medical Services. According to data from OpenAlex, James S. Kaufman has authored 114 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Nephrology, 23 papers in Pulmonary and Respiratory Medicine and 21 papers in Emergency Medical Services. Recurrent topics in James S. Kaufman's work include Dialysis and Renal Disease Management (37 papers), Acute Kidney Injury Research (30 papers) and Chronic Kidney Disease and Diabetes (28 papers). James S. Kaufman is often cited by papers focused on Dialysis and Renal Disease Management (37 papers), Acute Kidney Injury Research (30 papers) and Chronic Kidney Disease and Diabetes (28 papers). James S. Kaufman collaborates with scholars based in United States, Canada and Spain. James S. Kaufman's co-authors include Mae Thamer, Dennis J. Cotter, Tom Greene, Michael Allon, Daniel R. Brooks, Daniel E. Weiner, David S. Goldfarb, Yi Zhang, Chirag R. Parikh and Laura M. Dember and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

James S. Kaufman

112 papers receiving 6.1k citations

Hit Papers

Effect of Clopidogrel on Early Failure of Arteriovenous F... 2007 2026 2013 2019 2008 2007 2017 100 200 300 400 500

Peers

James S. Kaufman
Bernard G. Jaar United States
Elani Streja United States
Daniel E. Weiner United States
David T. Gilbertson United States
David A. Goodkin United States
Bernard G. Jaar United States
James S. Kaufman
Citations per year, relative to James S. Kaufman James S. Kaufman (= 1×) peers Bernard G. Jaar

Countries citing papers authored by James S. Kaufman

Since Specialization
Citations

This map shows the geographic impact of James S. Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Kaufman more than expected).

Fields of papers citing papers by James S. Kaufman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Kaufman. The network helps show where James S. Kaufman may publish in the future.

Co-authorship network of co-authors of James S. Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of James S. Kaufman. A scholar is included among the top collaborators of James S. Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S. Kaufman. James S. Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Yumeng, Steven Menez, Heather Thiessen‐Philbrook, et al.. (2025). Urine proteomic signatures of kidney function decline after hospitalization. JCI Insight. 10(20).
2.
Bhatraju, Pavan K., Leila R. Zelnick, Ian B. Stanaway, et al.. (2024). Acute Kidney Injury, Systemic Inflammation, and Long-Term Cognitive Function. Clinical Journal of the American Society of Nephrology. 19(7). 829–836. 2 indexed citations
3.
Menez, Steven, Kathleen F. Kerr, Heather Thiessen‐Philbrook, et al.. (2024). Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury Survivors. Clinical Journal of the American Society of Nephrology. 20(3). 337–345. 3 indexed citations
4.
Menez, Steven, Yumeng Wen, Leyuan Xu, et al.. (2023). The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events. Kidney International. 104(6). 1194–1205. 18 indexed citations
5.
Rein, Joshua L., Hui Zeng, Kinsuk Chauhan, et al.. (2023). A Retrospective Cohort Study That Examined the Impact of Cannabis Consumption on Long-Term Kidney Outcomes. Cannabis and Cannabinoid Research. 9(2). 635–645. 6 indexed citations
6.
Bhatraju, Pavan K., David K. Prince, Sherry G. Mansour, et al.. (2023). Integrated Analysis of Blood and Urine Biomarkers to Identify Acute Kidney Injury Subphenotypes and Associations With Long-term Outcomes. American Journal of Kidney Diseases. 82(3). 311–321.e1. 8 indexed citations
7.
Wen, Yumeng, Leyuan Xu, Heather Thiessen‐Philbrook, et al.. (2023). Longitudinal biomarkers and kidney disease progression after acute kidney injury. JCI Insight. 8(9). 29 indexed citations
8.
Weisbord, Steven D., Paul M. Palevsky, James S. Kaufman, et al.. (2020). Contrast-Associated Acute Kidney Injury and Serious Adverse Outcomes Following Angiography. Journal of the American College of Cardiology. 75(11). 1311–1320. 61 indexed citations
9.
Hsu, Chi‐yuan, Vernon M. Chinchilli, Steven G. Coca, et al.. (2020). Post–Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression. JAMA Internal Medicine. 180(3). 402–402. 108 indexed citations
10.
Ramírez‐Rubio, Oriana, Rebecca L. Laws, Michael D. McClean, et al.. (2017). Leptospiraseropositivity as a risk factor for Mesoamerican Nephropathy. International Journal of Occupational and Environmental Health. 23(1). 1–10. 40 indexed citations
11.
Weisbord, Steven D., Martin Gallagher, Hani Jneid, et al.. (2017). Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. New England Journal of Medicine. 378(7). 603–614. 292 indexed citations breakdown →
13.
Stroupe, Kevin T., Michael J. Fischer, James S. Kaufman, et al.. (2011). Predialysis Nephrology Care and Costs in Elderly Patients Initiating Dialysis. Medical Care. 49(3). 248–256. 22 indexed citations
14.
O’Hare, Ann M., Andy I. Choi, Daniel Bertenthal, et al.. (2007). Age Affects Outcomes in Chronic Kidney Disease. Journal of the American Society of Nephrology. 18(10). 2758–2765. 505 indexed citations breakdown →
15.
Cotter, David, et al.. (2007). The effect of epoetin dose on hematocrit. Kidney International. 73(3). 347–353. 20 indexed citations
16.
O’Hare, Ann M., Daniel Bertenthal, Louise C. Walter, et al.. (2007). When to refer patients with chronic kidney disease for vascular access surgery: Should age be a consideration?. Kidney International. 71(6). 555–561. 100 indexed citations
17.
Hynes, Denise M., Kevin T. Stroupe, James S. Kaufman, et al.. (2006). Adherence to Guidelines for ESRD Anemia Management. American Journal of Kidney Diseases. 47(3). 455–461. 22 indexed citations
18.
Dember, Laura M., et al.. (2004). Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International. 66(1). 390–398. 85 indexed citations
19.
Kaufman, James S., Domenic J. Reda, Carol L. Fye, et al.. (2001). Diagnostic value of iron indices in hemodialysis patients receiving epoetin. Kidney International. 60(1). 300–308. 16 indexed citations
20.
Oza, Narendra B., Catherine M. Murphy, Debbie Beasley, Norman G. Levinsky, & James S. Kaufman. (1989). A Micro-Kininogenase Assay for Studies of Kallikrein in Renal Micropuncture/Microperfusion. Advances in experimental medicine and biology. 247A. 549–554. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026